Supplementary Figure S1 from Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion Trial
<p>Supplementary Figure S1. Consort flow diagram of (A) patient disposition; (B) schematic of recruitment periods; and (C) treatment schedule. IL-2, interleukin-2; LTI, long-term infusion.</p>
Authors
- Evgenia Glogova
- Thomas Klingebiel (ORCID: https://orcid.org/0000-0001-5726-9092)
- Ruth Lydia Ladenstein (ORCID: https://orcid.org/0000-0001-6548-3873)
- Dominique Valteau‐Couanet (ORCID: https://orcid.org/0009-0001-9880-2241)
- Holger N. Lode (ORCID: https://orcid.org/0000-0002-1201-208X)
- Ulrike Pötschger (ORCID: https://orcid.org/0000-0001-7024-7082)
- Nikolai Siebert (ORCID: https://orcid.org/0000-0001-6254-1302)
- Jean Michon (ORCID: https://orcid.org/0000-0002-2935-2750)
- Juliet C. Gray (ORCID: https://orcid.org/0000-0002-5652-4722)
- Adela Cañete (ORCID: https://orcid.org/0000-0002-5669-5097)
- Roberto Luksch (ORCID: https://orcid.org/0000-0002-7203-4176)
- Isaac Yaniv (ORCID: https://orcid.org/0009-0005-1063-5872)
- Sascha Troschke‐Meurer (ORCID: https://orcid.org/0000-0002-6185-462X)
- Cormac Owens (ORCID: https://orcid.org/0000-0001-6559-3239)
- Shifra Ash (ORCID: https://orcid.org/0000-0003-4278-1645)
- Carla Manzitti (ORCID: https://orcid.org/0000-0002-1501-5518)
- Alberto Garaventa (ORCID: https://orcid.org/0000-0002-5368-6363)
- Hans Loibner (ORCID: https://orcid.org/0000-0001-8159-9083)
- John W. Anderson
Publication Details
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1158/1078-0432.30028898
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00